Aurora Cannabis Files 6-K, Incorporates Material Change Report

Ticker: ACB · Form: 6-K · Filed: 2024-02-16T00:00:00.000Z

Sentiment: neutral

Topics: 6-K filing, material change, foreign private issuer

TL;DR

**Aurora Cannabis just filed a 6-K, incorporating a material change report, so keep an eye out for what that change is!**

AI Summary

Aurora Cannabis Inc. filed a 6-K report on February 16, 2024, for the month of February 2024, indicating it is a foreign private issuer. The filing incorporates by reference a Material Change Report dated February 15, 2024, into its Registration Statement on Form F-10 (File No. 333-271479). The report was signed by Glen Ibbott, Chief Financial Officer of Aurora Cannabis Inc.

Why It Matters

This filing signals a recent material change at Aurora Cannabis, which could impact investors and company operations, though the specific details of the change are not provided in this 6-K.

Risk Assessment

Risk Level: medium — The filing mentions a 'Material Change Report' but does not disclose the nature of the change, which introduces uncertainty for investors.

Key Players & Entities

FAQ

What type of report did Aurora Cannabis Inc. file?

Aurora Cannabis Inc. filed a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

When was this 6-K report filed?

The 6-K report was filed on February 16, 2024, for the month of February 2024.

What specific document is incorporated by reference in this 6-K?

This Form 6-K incorporates by reference a Material Change Report dated February 15, 2024.

Into which registration statement is the Material Change Report incorporated?

The Material Change Report is incorporated into the registrant's Registration Statement on Form F-10 (File No. 333-271479).

Who signed the 6-K report on behalf of Aurora Cannabis Inc.?

The 6-K report was signed by Glen Ibbott, Chief Financial Officer of Aurora Cannabis Inc.

From the Filing

0001279569-24-000158.txt : 20240216 0001279569-24-000158.hdr.sgml : 20240216 20240216094918 ACCESSION NUMBER: 0001279569-24-000158 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240215 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 24646073 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW, Edmonton, Alberta, Canada T6X 1V8 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ I NCORPORATION BY REFERENCE This Form 6-K is hereby filed and incorporated by reference in the registrant’s Registration Statement on Form F-10 (File No. 333-271479). SUBMITTED HEREWITH Exhibits Description 99.1 Material Change Report dated February 15, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Glen Ibbott Glen Ibbott Chief Financial Officer Date: February 15, 2024 EX-99.1 2 ex991.htm MATERIAL CHANGE REPORT DATED FEBRUARY 15, 2024 Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 	Name and Address of Company Aurora Cannabis Inc. (“ Aurora ” or the “ Company ”) 2207-90b Street SW Edmonton, Alberta T6X 1V8 Item 2 	Date of Material Change February 7 , 2024 Item 3 	News Release A press release describing the material change was disseminated by Aurora on February 8, 2024 through Cision PR Newswire and can be found on SEDAR+ at www.sedarplus.ca. Item 4 	Summary of Material Change A wholly-owned subsidiary (“ Aurora Sub ”) acquired the remaining approximately 90% equity interest that Aurora did not previously own of Indica Industries Pty Ltd (“ MedReleaf Australia ”), a leading distributor of medical cannabis products, for an enterprise value of AUD$50 million, subject to customary adjustments. Aurora paid AUD$9.45 million in cash with the balance of the purchase price satisfied by the issuance of common shares of Aurora (the “ Aurora Shares ”). Item 5 	Full Description of Material Change 5.1 Full Description of Material Change On February 7, 2024, Aurora, through Aurora Sub, purchased the remaining approximately 90% equity interest of MedReleaf Australia at a total enterprise value of AUD$50 million subject to customary adjustments (the “ Transaction ”). As consideration, Aurora (i) issued the selling shareholders an aggregate of 69,489,941 Aurora Shares (the “ Share Consideration ”); and (ii) paid the selling shareholders AUD$9.45 million in cash (the “ Cash Consideration ” and together with the Share Consideration, the “ Consideration ”), subject to customary adjustments post-closing. Approximately 10% of the Consideration will be held in escrow to ensure certain obligations of the selling shareholders. 5.2 Disclosure for Restructuring Transactions Not applicable . Item

View on Read The Filing